FAKTOR OPTIONSSCHEIN - JOHNSON & JOHNSON Share Price

Certificat

DE000UH2CBB4

Market Closed - Deutsche Boerse AG 10:56:10 21/06/2024 pm IST
1.54 EUR +1.99% Intraday chart for FAKTOR OPTIONSSCHEIN - JOHNSON & JOHNSON
Current month+2.67%
1 month-8.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
21/24/21 1.54 +1.99%
20/24/20 1.51 +8.63%
19/24/19 1.39 -2.80%
18/24/18 1.43 0.00%
17/24/17 1.43 +0.70%

Delayed Quote Deutsche Boerse AG

Last update June 21, 2024 at 10:56 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying JOHNSON & JOHNSON
Issuer UBS
WKN UH2CBB
ISINDE000UH2CBB4
Date issued 13/09/2021
Strike 110.8 $
Maturity Unlimited
Parity 22.57 : 1
Emission price 4.93
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 7.23
Lowest since issue 1.35
Spread 0.05
Spread %3.14%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
148.8 USD
Average target price
171.7 USD
Spread / Average Target
+15.44%
Consensus